Denmark vs Switzerland: Access to anti-retroviral drugs, female
Denmark
91.0%
in 2023
Switzerland
90.0%
in 2023
Denmark rank
25th
Switzerland rank
27th
Access to anti-retroviral drugs, female over time
- Denmark
- Switzerland
How they compare
Denmark currently reports 91.0% against 90.0% in Switzerland, a difference of 1.0%.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Denmark ahead.
Denmark ranks 25th and Switzerland ranks 27th of 141 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.0% | 54.5% | 3.5% | Switzerland |
| 2010s | 77.9% | 83.6% | 5.7% | Switzerland |
| 2020s | 88.0% | 90.5% | 2.5% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Denmark or Switzerland?
- Denmark, at 91.0% against 90.0% in Switzerland as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Denmark and Switzerland?
- 1.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Switzerland?
- 24 years are reported by both, from 2000 to 2023.
- How do Denmark and Switzerland rank globally for access to anti-retroviral drugs, female?
- Denmark ranks 25th and Switzerland ranks 27th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.